- MemberJuly 8, 2020 at 10:46 am
I understand. However, I would like to point out that they have 150 scientists with PHD’s working on creating molecules which they can then sell to companies such as Bristol Meyer Squib or other large pharmaceuticals. I am not aware of any other company which is in direct competition with them, and they have signed a deal to use Google’s computing power to increase the speed at which these new molecules can be created. Lastly, although they are currently losing money, they have large backers such as Bill Gates from whom I suppose they can raise additional capital from.
Thank you. Please let me know if you think this can justify the valuation, at least partially